TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/6/22 16:06 | 7/1/22 | CVET | Covetrus, Inc. | DE | Retail | DrugSt | Drug Stores & Proprietary Sto | Fonteyne Paul R. | ME | D | M.d | 0 | 0.00 | 0 | 8 | 166 | 13 | D | |||||||||||||||
1/10/22 20:37 | 1/6/22 | AMLX | Amylyx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fonteyne Paul R. | MA | D | P.d | 75 | 19.00 | 0 | 4 | New | 4 | D | |||||||||||||||
8/11/21 16:09 | 8/10/21 | CVET | Covetrus, Inc. | DE | Retail | DrugSt | Drug Stores & Proprietary Sto | Fonteyne Paul R. | ME | D | P | 116 | 23.24 | 0 | 5 | New | 5 | D | |||||||||||||||
5/12/20 17:53 | 5/8/20 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fonteyne Paul R. | MA | D | P | 159 | 31.81 | 0 | 5 | New | 5 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |